Healthscope (HSP) Stock Recommendation

Macquarie Research Equities have reiterated their Outperform recommendation for the Healthscope (HSP) stock with a 12 month share price target of $5.15. They have commented that the company result was better than expected and that their margins were better than expected. HSP achieved a 14.3 percent in underlying EBITDA margins in 2H06, which is typically a seasonally weak half in private hospital operations. Also, the stock analyst have noted that Healthscope's operating cash-flow is superb with operating cashflow generation was a highlight of the result at 100% of underlying EBITDA, and may alleviate tax-related quality concerns.

Healthscope Limited is listed on the Australian Stock Exchange (ASX) under stock code HSP. You can view their investor website here. HSP stock listed on the ASX on 4 May, 1994. The company is involved in the ownership and operation of hospitals. Find out the meaning of the recommendations in this primer. Browse for other broker recommendations. Check your charts and good luck with your share trading!